A double-blind, randomized, vehicle controlled, crossover study to evaluate the safety and efficacy of topical naloxone hydrochloride lotion, 0.5%, for the relief of pruritus in patients with the mycfungoides (MF) form of cutaneous t-cell lymphoma (CTCL)
|Effective start/end date||10/1/17 → 2/20/24|
- ELORAC INC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.